 | • レポートコード：MRC2-11QY11918 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は第IX因子欠乏症治療のグローバル市場について調査・分析したレポートです。種類別（血友病B、血友病B阻害剤）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別第IX因子欠乏症治療の競争状況、市場シェア ・世界の第IX因子欠乏症治療市場：種類別市場規模 2015年-2020年（血友病B、血友病B阻害剤） ・世界の第IX因子欠乏症治療市場：種類別市場規模予測 2021年-2026年（血友病B、血友病B阻害剤） ・世界の第IX因子欠乏症治療市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界の第IX因子欠乏症治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米の第IX因子欠乏症治療市場分析：米国、カナダ ・ヨーロッパの第IX因子欠乏症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの第IX因子欠乏症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の第IX因子欠乏症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの第IX因子欠乏症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Takeda、Novo Nordisk、Biogen、CSL Behring ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B.
In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market during the forecast period. Factors such a low cost and high efficiency are the key contributors to the dominance of this segment in the global market.
Market Analysis and Insights: Global Factor IX Deficiency Treatment Market
The global Factor IX Deficiency Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Factor IX Deficiency Treatment Scope and Market Size
Factor IX Deficiency Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Factor IX Deficiency Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Takeda
Novo Nordisk
Biogen
CSL Behring
…
Market segment by Type, the product can be split into
Hemophilia B
Hemophilia B Inhibitors
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Factor IX Deficiency Treatment Revenue
1.4 Market by Type
1.4.1 Global Factor IX Deficiency Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hemophilia B
1.4.3 Hemophilia B Inhibitors
1.5 Market by Application
1.5.1 Global Factor IX Deficiency Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Factor IX Deficiency Treatment Market Perspective (2015-2026)
2.2 Global Factor IX Deficiency Treatment Growth Trends by Regions
2.2.1 Factor IX Deficiency Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Factor IX Deficiency Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Factor IX Deficiency Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Factor IX Deficiency Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Factor IX Deficiency Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Factor IX Deficiency Treatment Players by Market Size
3.1.1 Global Top Factor IX Deficiency Treatment Players by Revenue (2015-2020)
3.1.2 Global Factor IX Deficiency Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Factor IX Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Factor IX Deficiency Treatment Market Concentration Ratio
3.2.1 Global Factor IX Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Factor IX Deficiency Treatment Revenue in 2019
3.3 Factor IX Deficiency Treatment Key Players Head office and Area Served
3.4 Key Players Factor IX Deficiency Treatment Product Solution and Service
3.5 Date of Enter into Factor IX Deficiency Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Factor IX Deficiency Treatment Historic Market Size by Type (2015-2020)
4.2 Global Factor IX Deficiency Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Factor IX Deficiency Treatment Market Size by Application (2015-2020)
5.2 Global Factor IX Deficiency Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Factor IX Deficiency Treatment Market Size (2015-2020)
6.2 Factor IX Deficiency Treatment Key Players in North America (2019-2020)
6.3 North America Factor IX Deficiency Treatment Market Size by Type (2015-2020)
6.4 North America Factor IX Deficiency Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Factor IX Deficiency Treatment Market Size (2015-2020)
7.2 Factor IX Deficiency Treatment Key Players in Europe (2019-2020)
7.3 Europe Factor IX Deficiency Treatment Market Size by Type (2015-2020)
7.4 Europe Factor IX Deficiency Treatment Market Size by Application (2015-2020)
8 China
8.1 China Factor IX Deficiency Treatment Market Size (2015-2020)
8.2 Factor IX Deficiency Treatment Key Players in China (2019-2020)
8.3 China Factor IX Deficiency Treatment Market Size by Type (2015-2020)
8.4 China Factor IX Deficiency Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Factor IX Deficiency Treatment Market Size (2015-2020)
9.2 Factor IX Deficiency Treatment Key Players in Japan (2019-2020)
9.3 Japan Factor IX Deficiency Treatment Market Size by Type (2015-2020)
9.4 Japan Factor IX Deficiency Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Factor IX Deficiency Treatment Market Size (2015-2020)
10.2 Factor IX Deficiency Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Factor IX Deficiency Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Factor IX Deficiency Treatment Market Size by Application (2015-2020)
11 India
11.1 India Factor IX Deficiency Treatment Market Size (2015-2020)
11.2 Factor IX Deficiency Treatment Key Players in India (2019-2020)
11.3 India Factor IX Deficiency Treatment Market Size by Type (2015-2020)
11.4 India Factor IX Deficiency Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Factor IX Deficiency Treatment Market Size (2015-2020)
12.2 Factor IX Deficiency Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Factor IX Deficiency Treatment Market Size by Type (2015-2020)
12.4 Central & South America Factor IX Deficiency Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Factor IX Deficiency Treatment Introduction
13.1.4 Pfizer Revenue in Factor IX Deficiency Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Takeda
13.2.1 Takeda Company Details
13.2.2 Takeda Business Overview
13.2.3 Takeda Factor IX Deficiency Treatment Introduction
13.2.4 Takeda Revenue in Factor IX Deficiency Treatment Business (2015-2020)
13.2.5 Takeda Recent Development
13.3 Novo Nordisk
13.3.1 Novo Nordisk Company Details
13.3.2 Novo Nordisk Business Overview
13.3.3 Novo Nordisk Factor IX Deficiency Treatment Introduction
13.3.4 Novo Nordisk Revenue in Factor IX Deficiency Treatment Business (2015-2020)
13.3.5 Novo Nordisk Recent Development
13.4 Biogen
13.4.1 Biogen Company Details
13.4.2 Biogen Business Overview
13.4.3 Biogen Factor IX Deficiency Treatment Introduction
13.4.4 Biogen Revenue in Factor IX Deficiency Treatment Business (2015-2020)
13.4.5 Biogen Recent Development
13.5 CSL Behring
13.5.1 CSL Behring Company Details
13.5.2 CSL Behring Business Overview
13.5.3 CSL Behring Factor IX Deficiency Treatment Introduction
13.5.4 CSL Behring Revenue in Factor IX Deficiency Treatment Business (2015-2020)
13.5.5 CSL Behring Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Factor IX Deficiency Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Factor IX Deficiency Treatment Revenue
Table 3. Ranking of Global Top Factor IX Deficiency Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Factor IX Deficiency Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hemophilia B
Table 6. Key Players of Hemophilia B Inhibitors
Table 7. Global Factor IX Deficiency Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Factor IX Deficiency Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Factor IX Deficiency Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Factor IX Deficiency Treatment Market Share by Regions (2015-2020)
Table 11. Global Factor IX Deficiency Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Factor IX Deficiency Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Factor IX Deficiency Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Factor IX Deficiency Treatment Players
Table 18. Global Factor IX Deficiency Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Factor IX Deficiency Treatment Market Share by Players (2015-2020)
Table 20. Global Top Factor IX Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Factor IX Deficiency Treatment as of 2019)
Table 21. Global Factor IX Deficiency Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Factor IX Deficiency Treatment Product Solution and Service
Table 24. Date of Enter into Factor IX Deficiency Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Factor IX Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Factor IX Deficiency Treatment Market Size Share by Type (2015-2020)
Table 28. Global Factor IX Deficiency Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Factor IX Deficiency Treatment Market Size Share by Application (2015-2020)
Table 30. Global Factor IX Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Factor IX Deficiency Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Factor IX Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Factor IX Deficiency Treatment Market Share (2019-2020)
Table 34. North America Factor IX Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Factor IX Deficiency Treatment Market Share by Type (2015-2020)
Table 36. North America Factor IX Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Factor IX Deficiency Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Factor IX Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Factor IX Deficiency Treatment Market Share (2019-2020)
Table 40. Europe Factor IX Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Factor IX Deficiency Treatment Market Share by Type (2015-2020)
Table 42. Europe Factor IX Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Factor IX Deficiency Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Factor IX Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Factor IX Deficiency Treatment Market Share (2019-2020)
Table 46. China Factor IX Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Factor IX Deficiency Treatment Market Share by Type (2015-2020)
Table 48. China Factor IX Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Factor IX Deficiency Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Factor IX Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Factor IX Deficiency Treatment Market Share (2019-2020)
Table 52. Japan Factor IX Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Factor IX Deficiency Treatment Market Share by Type (2015-2020)
Table 54. Japan Factor IX Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Factor IX Deficiency Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Factor IX Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Factor IX Deficiency Treatment Market Share (2019-2020)
Table 58. Southeast Asia Factor IX Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Factor IX Deficiency Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Factor IX Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Factor IX Deficiency Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Factor IX Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Factor IX Deficiency Treatment Market Share (2019-2020)
Table 64. India Factor IX Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Factor IX Deficiency Treatment Market Share by Type (2015-2020)
Table 66. India Factor IX Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Factor IX Deficiency Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Factor IX Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Factor IX Deficiency Treatment Market Share (2019-2020)
Table 70. Central & South America Factor IX Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Factor IX Deficiency Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Factor IX Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Factor IX Deficiency Treatment Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Factor IX Deficiency Treatment Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Takeda Company Details
Table 80. Takeda Business Overview
Table 81. Takeda Product
Table 82. Takeda Revenue in Factor IX Deficiency Treatment Business (2015-2020) (Million US$)
Table 83. Takeda Recent Development
Table 84. Novo Nordisk Company Details
Table 85. Novo Nordisk Business Overview
Table 86. Novo Nordisk Product
Table 87. Novo Nordisk Revenue in Factor IX Deficiency Treatment Business (2015-2020) (Million US$)
Table 88. Novo Nordisk Recent Development
Table 89. Biogen Company Details
Table 90. Biogen Business Overview
Table 91. Biogen Product
Table 92. Biogen Revenue in Factor IX Deficiency Treatment Business (2015-2020) (Million US$)
Table 93. Biogen Recent Development
Table 94. CSL Behring Company Details
Table 95. CSL Behring Business Overview
Table 96. CSL Behring Product
Table 97. CSL Behring Revenue in Factor IX Deficiency Treatment Business (2015-2020) (Million US$)
Table 98. CSL Behring Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Factor IX Deficiency Treatment Market Share by Type: 2020 VS 2026
Figure 2. Hemophilia B Features
Figure 3. Hemophilia B Inhibitors Features
Figure 4. Global Factor IX Deficiency Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Other Case Studies
Figure 8. Factor IX Deficiency Treatment Report Years Considered
Figure 9. Global Factor IX Deficiency Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Factor IX Deficiency Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Factor IX Deficiency Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Factor IX Deficiency Treatment Market Share by Players in 2019
Figure 14. Global Top Factor IX Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Factor IX Deficiency Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Factor IX Deficiency Treatment Revenue in 2019
Figure 16. North America Factor IX Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Factor IX Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Factor IX Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Factor IX Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Factor IX Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Factor IX Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Factor IX Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
第VIII因子欠乏症治療の世界市場（～2026年） Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endotheli…- 血友病A・B組換え因子補充療法の世界市場（～2026年） Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…
- 成長ホルモン欠乏症治療の世界市場（～2026年） Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction. The primary factor contributing to the growth of global growth hormone deficie…
- チロシンヒドロキシラーゼ欠損症治療の世界市場（～2026年） The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…
- ビタミン欠乏症治療の世界市場（～2026年） Vitamin deficiency, also called as hypovitaminosis, is primarily caused by malnutrition. The global vitamin deficiency treatment market is highly fragmented with large number of local as well as strong players. Market Analysis and Insights: Global Vitamin Deficiency Treatment Market The global Vitam…